Paul Seib
Concepts (167)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Extracorporeal Membrane Oxygenation | 5 | 2016 | 287 | 0.510 |
Why?
| Cardiac Surgical Procedures | 3 | 2016 | 298 | 0.430 |
Why?
| Pulmonary Artery | 2 | 2011 | 145 | 0.430 |
Why?
| Angioplasty, Balloon | 1 | 2010 | 65 | 0.360 |
Why?
| Stents | 2 | 2010 | 338 | 0.350 |
Why?
| Arterial Occlusive Diseases | 1 | 2010 | 81 | 0.350 |
Why?
| Heart Transplantation | 9 | 2012 | 312 | 0.320 |
Why?
| Down Syndrome | 2 | 2021 | 91 | 0.310 |
Why?
| Infant | 17 | 2021 | 3551 | 0.290 |
Why?
| Child, Preschool | 16 | 2017 | 3853 | 0.260 |
Why?
| Heart Defects, Congenital | 2 | 2010 | 592 | 0.250 |
Why?
| Child | 19 | 2021 | 6824 | 0.230 |
Why?
| Heart Diseases | 4 | 2012 | 208 | 0.210 |
Why?
| Cardiac Catheterization | 4 | 2012 | 196 | 0.210 |
Why?
| Heart-Assist Devices | 3 | 2013 | 147 | 0.200 |
Why?
| DiGeorge Syndrome | 1 | 2021 | 20 | 0.190 |
Why?
| Cardiomyopathy, Dilated | 2 | 2008 | 36 | 0.180 |
Why?
| Tetralogy of Fallot | 1 | 2021 | 86 | 0.180 |
Why?
| Kidney | 3 | 2013 | 665 | 0.180 |
Why?
| Punctures | 1 | 1999 | 47 | 0.160 |
Why?
| Retrospective Studies | 11 | 2021 | 6117 | 0.160 |
Why?
| Adolescent | 13 | 2016 | 6340 | 0.160 |
Why?
| Catheterization | 1 | 1999 | 97 | 0.160 |
Why?
| Oxygen Consumption | 2 | 2011 | 180 | 0.160 |
Why?
| Ventricular Dysfunction, Left | 1 | 1999 | 92 | 0.150 |
Why?
| Treatment Outcome | 10 | 2016 | 5138 | 0.150 |
Why?
| Infant, Newborn | 8 | 2016 | 2744 | 0.150 |
Why?
| Heart Failure | 2 | 2013 | 454 | 0.150 |
Why?
| Child, Hospitalized | 1 | 2017 | 30 | 0.150 |
Why?
| Child Health Services | 1 | 2017 | 77 | 0.140 |
Why?
| Hospitals, Pediatric | 1 | 2017 | 239 | 0.140 |
Why?
| Critical Illness | 1 | 2017 | 286 | 0.120 |
Why?
| Heart Arrest | 1 | 2016 | 148 | 0.120 |
Why?
| Spectroscopy, Near-Infrared | 2 | 2011 | 53 | 0.110 |
Why?
| Humans | 23 | 2021 | 49827 | 0.110 |
Why?
| Atrial Appendage | 1 | 2012 | 11 | 0.110 |
Why?
| Echocardiography | 3 | 2011 | 378 | 0.110 |
Why?
| Dexmedetomidine | 1 | 2012 | 21 | 0.110 |
Why?
| Fistula | 1 | 2012 | 24 | 0.100 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 75 | 0.100 |
Why?
| Aortic Diseases | 1 | 2012 | 54 | 0.100 |
Why?
| Aorta, Thoracic | 1 | 2012 | 92 | 0.100 |
Why?
| Age Factors | 4 | 2010 | 1090 | 0.100 |
Why?
| Fontan Procedure | 1 | 2012 | 63 | 0.100 |
Why?
| Tricuspid Valve Insufficiency | 1 | 2011 | 14 | 0.100 |
Why?
| Kidney Failure, Chronic | 1 | 2013 | 197 | 0.100 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2012 | 97 | 0.100 |
Why?
| Time Factors | 5 | 2010 | 2912 | 0.090 |
Why?
| Retreatment | 1 | 2010 | 58 | 0.090 |
Why?
| Male | 15 | 2017 | 25093 | 0.090 |
Why?
| Constriction, Pathologic | 1 | 2010 | 94 | 0.090 |
Why?
| Intraoperative Care | 1 | 2010 | 56 | 0.090 |
Why?
| Echocardiography, Doppler | 1 | 2010 | 52 | 0.090 |
Why?
| Female | 15 | 2017 | 26329 | 0.090 |
Why?
| Recurrence | 2 | 2010 | 651 | 0.090 |
Why?
| Graft Rejection | 1 | 2010 | 159 | 0.090 |
Why?
| Proportional Hazards Models | 1 | 2010 | 406 | 0.080 |
Why?
| Kaplan-Meier Estimate | 1 | 2010 | 469 | 0.080 |
Why?
| Patient Transfer | 1 | 2010 | 95 | 0.080 |
Why?
| Pipecolic Acids | 1 | 2008 | 7 | 0.080 |
Why?
| Cesium | 1 | 2008 | 8 | 0.080 |
Why?
| Chlorides | 1 | 2008 | 51 | 0.080 |
Why?
| Oxygen | 1 | 2011 | 325 | 0.080 |
Why?
| Jugular Veins | 1 | 2008 | 31 | 0.080 |
Why?
| Drug-Eluting Stents | 1 | 2008 | 93 | 0.080 |
Why?
| Arkansas | 2 | 2010 | 1967 | 0.080 |
Why?
| Superior Vena Cava Syndrome | 1 | 2007 | 11 | 0.080 |
Why?
| Heparin | 1 | 2008 | 92 | 0.080 |
Why?
| Coronary Disease | 1 | 2008 | 132 | 0.080 |
Why?
| Thrombocytopenia | 1 | 2008 | 84 | 0.080 |
Why?
| Decision Making | 1 | 2010 | 262 | 0.070 |
Why?
| Risk Factors | 3 | 2016 | 3619 | 0.070 |
Why?
| Angioplasty, Balloon, Coronary | 1 | 2008 | 130 | 0.070 |
Why?
| Catheterization, Central Venous | 1 | 2008 | 87 | 0.070 |
Why?
| Electrocardiography | 1 | 2008 | 253 | 0.070 |
Why?
| Oximetry | 1 | 2007 | 66 | 0.070 |
Why?
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 119 | 0.070 |
Why?
| Vascular Malformations | 1 | 2008 | 98 | 0.070 |
Why?
| Risk Assessment | 1 | 2010 | 1262 | 0.070 |
Why?
| Cerebrovascular Circulation | 1 | 2007 | 131 | 0.070 |
Why?
| Cerebral Cortex | 1 | 2007 | 200 | 0.070 |
Why?
| Anticoagulants | 1 | 2008 | 254 | 0.060 |
Why?
| Hospital Mortality | 2 | 2016 | 413 | 0.060 |
Why?
| Databases, Factual | 2 | 2017 | 664 | 0.060 |
Why?
| Odds Ratio | 2 | 2017 | 548 | 0.050 |
Why?
| Blood Pressure | 2 | 2011 | 514 | 0.050 |
Why?
| Young Adult | 1 | 2010 | 3936 | 0.050 |
Why?
| Hospitals | 1 | 2021 | 175 | 0.040 |
Why?
| Length of Stay | 2 | 2016 | 623 | 0.040 |
Why?
| Pulmonary Edema | 1 | 1999 | 19 | 0.040 |
Why?
| Heart Septum | 1 | 1999 | 23 | 0.040 |
Why?
| Heart Atria | 1 | 1999 | 55 | 0.040 |
Why?
| Heart Septal Defects, Atrial | 1 | 1999 | 44 | 0.040 |
Why?
| Hypertrophy, Left Ventricular | 1 | 1998 | 34 | 0.040 |
Why?
| Circadian Rhythm | 1 | 1998 | 87 | 0.040 |
Why?
| Opportunistic Infections | 1 | 1997 | 59 | 0.040 |
Why?
| Reproducibility of Results | 2 | 2011 | 1188 | 0.040 |
Why?
| Waiting Lists | 1 | 1997 | 50 | 0.040 |
Why?
| Incidence | 2 | 2016 | 1003 | 0.040 |
Why?
| Quality of Health Care | 1 | 2017 | 185 | 0.030 |
Why?
| Critical Care | 1 | 2017 | 201 | 0.030 |
Why?
| Prospective Studies | 2 | 2011 | 2344 | 0.030 |
Why?
| Aortography | 1 | 2012 | 35 | 0.030 |
Why?
| Hypertension | 1 | 1998 | 532 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 197 | 0.030 |
Why?
| Radiography, Interventional | 1 | 2012 | 60 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2012 | 282 | 0.030 |
Why?
| Patient Safety | 1 | 2012 | 101 | 0.030 |
Why?
| Pulmonary Valve Insufficiency | 1 | 2011 | 19 | 0.020 |
Why?
| Equipment Design | 1 | 2012 | 282 | 0.020 |
Why?
| Diastole | 1 | 2011 | 69 | 0.020 |
Why?
| Blood Flow Velocity | 1 | 2011 | 99 | 0.020 |
Why?
| Echocardiography, Doppler, Pulsed | 1 | 2010 | 8 | 0.020 |
Why?
| Echocardiography, Doppler, Color | 1 | 2010 | 23 | 0.020 |
Why?
| Ventricular Pressure | 1 | 2010 | 15 | 0.020 |
Why?
| Pulmonary Wedge Pressure | 1 | 2010 | 19 | 0.020 |
Why?
| Ventricular Function, Right | 1 | 2010 | 37 | 0.020 |
Why?
| Mitral Valve | 1 | 2010 | 49 | 0.020 |
Why?
| ROC Curve | 1 | 2010 | 232 | 0.020 |
Why?
| United States | 2 | 2017 | 4838 | 0.020 |
Why?
| Case-Control Studies | 1 | 2012 | 1128 | 0.020 |
Why?
| Intensive Care Units, Pediatric | 1 | 2010 | 168 | 0.020 |
Why?
| Dipyridamole | 1 | 2008 | 9 | 0.020 |
Why?
| Heparin Antagonists | 1 | 2008 | 7 | 0.020 |
Why?
| Protamines | 1 | 2008 | 8 | 0.020 |
Why?
| Thrombin | 1 | 2008 | 38 | 0.020 |
Why?
| International Normalized Ratio | 1 | 2008 | 29 | 0.020 |
Why?
| Biopsy | 1 | 2010 | 582 | 0.020 |
Why?
| Program Evaluation | 1 | 2010 | 349 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2008 | 207 | 0.020 |
Why?
| Drug Interactions | 1 | 2008 | 206 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2010 | 904 | 0.020 |
Why?
| Logistic Models | 1 | 2010 | 891 | 0.020 |
Why?
| Warfarin | 1 | 2008 | 86 | 0.020 |
Why?
| Angiography | 1 | 2007 | 126 | 0.020 |
Why?
| Sulfonamides | 1 | 2008 | 129 | 0.020 |
Why?
| Patient Compliance | 1 | 2008 | 230 | 0.020 |
Why?
| Aspirin | 1 | 2008 | 114 | 0.020 |
Why?
| Arginine | 1 | 2008 | 179 | 0.020 |
Why?
| Coronary Angiography | 1 | 2008 | 336 | 0.020 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2008 | 174 | 0.020 |
Why?
| Postoperative Period | 1 | 2007 | 172 | 0.020 |
Why?
| Adult | 2 | 1999 | 13160 | 0.020 |
Why?
| Carcinoma, Hepatocellular | 1 | 2008 | 194 | 0.020 |
Why?
| Cohort Studies | 1 | 2010 | 1422 | 0.020 |
Why?
| Liver Neoplasms | 1 | 2008 | 332 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2010 | 1159 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2007 | 2179 | 0.010 |
Why?
| Creatine | 1 | 1998 | 38 | 0.010 |
Why?
| Blood Pressure Monitoring, Ambulatory | 1 | 1998 | 36 | 0.010 |
Why?
| Albuminuria | 1 | 1998 | 47 | 0.010 |
Why?
| Actuarial Analysis | 1 | 1997 | 9 | 0.010 |
Why?
| Protozoan Infections | 1 | 1997 | 5 | 0.010 |
Why?
| Likelihood Functions | 1 | 1997 | 54 | 0.010 |
Why?
| Cytomegalovirus Infections | 1 | 1997 | 34 | 0.010 |
Why?
| Tissue and Organ Procurement | 1 | 1997 | 39 | 0.010 |
Why?
| Virus Diseases | 1 | 1997 | 40 | 0.010 |
Why?
| Forecasting | 1 | 1997 | 150 | 0.010 |
Why?
| Bacterial Infections | 1 | 1997 | 98 | 0.010 |
Why?
| Cause of Death | 1 | 1997 | 145 | 0.010 |
Why?
| Lung Diseases | 1 | 1997 | 93 | 0.010 |
Why?
| Bacteremia | 1 | 1997 | 92 | 0.010 |
Why?
| Mycoses | 1 | 1997 | 158 | 0.010 |
Why?
| Multivariate Analysis | 1 | 1997 | 585 | 0.010 |
Why?
| Survival Analysis | 1 | 1997 | 659 | 0.010 |
Why?
| Respiration, Artificial | 1 | 1997 | 265 | 0.010 |
Why?
| Survival Rate | 1 | 1997 | 905 | 0.010 |
Why?
|
|
Seib's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|